Reassessing the COPD Treatment & Management Landscape
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease that causes breathing to be difficult, and includes bronchitis and emphysema. COPD affects millions of Americans and is the third leading cause of death in the U.S., according to the American Lung Association.
This Disease Education Center is intended to provide the latest treatment breakthroughs, FDA approvals, changes in the standard of care, and more for clinicians treating patients with COPD.
Antibiotics and Systemic Corticosteroids Effective for Treating COPD ExacerbationMarch 2, 2020
Antibiotics and systemic corticosteroids are effective for treating patients with mild to severe exacerbations of chronic obstructive pulmonary disease (COPD), according to a systematic review and meta-analysis...
Glycopyrrolate Inhalation Powder Improves Lung Function in COPD Patients Despite Smoking StatusJanuary 31, 2020
Treatment with glycopyrrolate inhalation powder resulted in significant lung function improvements regardless of whether or not patients with chronic obstructive pulmonary disease (COPD) were current smokers ...
New Diagnostic Criteria Promotes Better, Faster Care for Patients with COPDJanuary 3, 2020
New diagnostic criteria published in the Journal of COPD Foundation may increase the number of patients diagnosed with COPD by up to 15%...
Vaping Lung Injuries Prompt Clinical Guideline DevelopmentDecember 5, 2019
Researchers at Intermountain Healthcare in Salt Lake City have developed best practice guidelines to help physicians identify and treat e-cigarette or vaping-associated lung injury.
Antibiotics Overprescribed for COPDNovember 3, 2019
Antibiotics are overprescribed for chronic obstructive pulmonary disease (COPD), and particularly for mild-to-moderate disease, a large observational study reveals.